Blood pressure drug boosts effectiveness of cancer therapy
Blood Pressure Drug Telmisartan Shows Promise in Boosting Cancer Therapy Effectiveness A groundbreaking study led by Dr. Tyler J. Curiel at the Dartmouth Cancer Center (DCC) reveals that telmisartan, an FDA-approved blood pressure medication, can significantly enhance the effectiveness of olaparib, a targeted cancer therapy. Published in The Journal for ImmunoTherapy of Cancer, the research … Read more